Journal ArticleOPEN ACCESS

A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men Living With HIV: GeSIDA Study 10 017

  • Ron R
  • Díaz-García C
  • Sendagorta E
  • et al.
Clinical Infectious Diseases (2025)
DOI: 10.1093/cid/ciaf435
3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Men who have sex with men (MSM) with HIV are at increased risk for anal cancer, largely attributable to persistent HPV infection. However, data on the nonavalent HPV vaccine (9vHPV) in MSM with HIV older than 26 remain sparse.

Cite

CITATION STYLE

APA

Ron, R., Díaz-García, C., Sendagorta, E., Cabello-Úbeda, A., Moreno, E., Crespillo-Andújar, C., … Serrano-Villar, S. (2025). A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men Living With HIV: GeSIDA Study 10 017. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf435

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free